265 related articles for article (PubMed ID: 27821802)
21. DNA damage response mediators MDC1 and 53BP1: constitutive activation and aberrant loss in breast and lung cancer, but not in testicular germ cell tumours.
Bartkova J; Horejsí Z; Sehested M; Nesland JM; Rajpert-De Meyts E; Skakkebaek NE; Stucki M; Jackson S; Lukas J; Bartek J
Oncogene; 2007 Nov; 26(53):7414-22. PubMed ID: 17546051
[TBL] [Abstract][Full Text] [Related]
22. Testicular germ cell tumours: the paradigm of chemo-sensitive solid tumours.
di Pietro A; Vries EG; Gietema JA; Spierings DC; de Jong S
Int J Biochem Cell Biol; 2005 Dec; 37(12):2437-56. PubMed ID: 16099193
[TBL] [Abstract][Full Text] [Related]
23. The Role of
Timmerman DM; Eleveld TF; Gillis AJM; Friedrichs CC; Hillenius S; Remmers TL; Sriram S; Looijenga LHJ
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769213
[TBL] [Abstract][Full Text] [Related]
24. Moving From Poly (ADP-Ribose) Polymerase Inhibition to Targeting DNA Repair and DNA Damage Response in Cancer Therapy.
Gourley C; Balmaña J; Ledermann JA; Serra V; Dent R; Loibl S; Pujade-Lauraine E; Boulton SJ
J Clin Oncol; 2019 Sep; 37(25):2257-2269. PubMed ID: 31050911
[TBL] [Abstract][Full Text] [Related]
25. Molecular Mechanisms of Resistance in Testicular Germ Cell Tumors - clinical Implications.
Kalavska K; Conteduca V; De Giorgi U; Mego M
Curr Cancer Drug Targets; 2018; 18(10):967-978. PubMed ID: 29295694
[TBL] [Abstract][Full Text] [Related]
26. [Analysis of gene expression of human tumor cells in testicular tumor].
Niclas C; Sparwasser C
Urologe A; 2007 Sep; 46(9):1185. PubMed ID: 17690861
[No Abstract] [Full Text] [Related]
27. Targeting DNA Damage Repair Pathways in Pancreatic Adenocarcinoma.
Das S; Cardin D
Curr Treat Options Oncol; 2020 Jun; 21(8):62. PubMed ID: 32601814
[TBL] [Abstract][Full Text] [Related]
28. Cisplatin hypersensitivity of testicular germ cell tumors is determined by high constitutive Noxa levels mediated by Oct-4.
Gutekunst M; Mueller T; Weilbacher A; Dengler MA; Bedke J; Kruck S; Oren M; Aulitzky WE; van der Kuip H
Cancer Res; 2013 Mar; 73(5):1460-9. PubMed ID: 23302226
[TBL] [Abstract][Full Text] [Related]
29. Critical role of CCDC6 in the neoplastic growth of testicular germ cell tumors.
Staibano S; Ilardi G; Leone V; Luise C; Merolla F; Esposito F; Morra F; Siano M; Franco R; Fusco A; Chieffi P; Celetti A
BMC Cancer; 2013 Sep; 13():433. PubMed ID: 24059746
[TBL] [Abstract][Full Text] [Related]
30. Orthoxenografts of Testicular Germ Cell Tumors Demonstrate Genomic Changes Associated with Cisplatin Resistance and Identify PDMP as a Resensitizing Agent.
Piulats JM; Vidal A; García-Rodríguez FJ; Muñoz C; Nadal M; Moutinho C; Martínez-Iniesta M; Mora J; Figueras A; Guinó E; Padullés L; Aytés À; Molleví DG; Puertas S; Martínez-Fernández C; Castillo W; Juliachs M; Moreno V; Muñoz P; Stefanovic M; Pujana MA; Condom E; Esteller M; Germà JR; Capella G; Farré L; Morales A; Viñals F; García-Del-Muro X; Cerón J; Villanueva A
Clin Cancer Res; 2018 Aug; 24(15):3755-3766. PubMed ID: 29618620
[No Abstract] [Full Text] [Related]
31. p53 and MDM2 in germ cell cancer treatment response.
Oliver RT; Shamash J; Berney DM
J Clin Oncol; 2002 Sep; 20(18):3928; author reply 3928-9. PubMed ID: 12228213
[No Abstract] [Full Text] [Related]
32. PCPH expression is an early event in the development of testicular germ cell tumors.
Regadera J; Blánquez MJ; González-Peramato P; Nistal M; Miller JC; Tirado OM; Notario V
Int J Oncol; 2006 Mar; 28(3):595-604. PubMed ID: 16465363
[TBL] [Abstract][Full Text] [Related]
33. Differential methylation EPIC analysis discloses cisplatin-resistance related hypermethylation and tumor-specific heterogeneity within matched primary and metastatic testicular germ cell tumor patient tissue samples.
Lobo J; Constâncio V; Leite-Silva P; Guimarães R; Cantante M; Braga I; Maurício J; Looijenga LHJ; Henrique R; Jerónimo C
Clin Epigenetics; 2021 Apr; 13(1):70. PubMed ID: 33823933
[TBL] [Abstract][Full Text] [Related]
34. Animacroxam, a Novel Dual-Mode Compound Targeting Histone Deacetylases and Cytoskeletal Integrity of Testicular Germ Cell Cancer Cells.
Steinemann G; Dittmer A; Kuzyniak W; Hoffmann B; Schrader M; Schobert R; Biersack B; Nitzsche B; Höpfner M
Mol Cancer Ther; 2017 Nov; 16(11):2364-2374. PubMed ID: 28838999
[TBL] [Abstract][Full Text] [Related]
35. Influence of vitamin D on cisplatin sensitivity in testicular germ cell cancer-derived cell lines and in a NTera2 xenograft model.
Jørgensen A; Blomberg Jensen M; Nielsen JE; Juul A; Rajpert-De Meyts E
J Steroid Biochem Mol Biol; 2013 Jul; 136():238-46. PubMed ID: 23098692
[TBL] [Abstract][Full Text] [Related]
36. Ghrelin Prevents Cisplatin-Induced Testicular Damage by Facilitating Repair of DNA Double Strand Breaks Through Activation of p53 in Mice.
Garcia JM; Chen JA; Guillory B; Donehower LA; Smith RG; Lamb DJ
Biol Reprod; 2015 Jul; 93(1):24. PubMed ID: 26019260
[TBL] [Abstract][Full Text] [Related]
37. p53 hypersensitivity is the predominant mechanism of the unique responsiveness of testicular germ cell tumor (TGCT) cells to cisplatin.
Gutekunst M; Oren M; Weilbacher A; Dengler MA; Markwardt C; Thomale J; Aulitzky WE; van der Kuip H
PLoS One; 2011 Apr; 6(4):e19198. PubMed ID: 21532991
[TBL] [Abstract][Full Text] [Related]
38. The relative activity of cisplatin, oxaliplatin and satraplatin in testicular germ cell tumour sensitive and resistant cell lines.
Perry J; Powles T; Shamash J; Veerupillai A; McGrowder E; Noel E; Lu YJ; Oliver T; Joel S
Cancer Chemother Pharmacol; 2009 Oct; 64(5):925-33. PubMed ID: 19263053
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of poly(ADP-ribose) polymerase (PARP) and ataxia telangiectasia mutated (ATM) on the chemosensitivity of mantle cell lymphoma to agents that induce DNA strand breaks.
Golla RM; Li M; Shen Y; Ji M; Yan Y; Fu K; Greiner TC; McKeithan TW; Chan WC
Hematol Oncol; 2012 Dec; 30(4):175-9. PubMed ID: 22170260
[TBL] [Abstract][Full Text] [Related]
40. Expression of splicing variants of the inhibitor of apoptosis livin in testicular germ cell tumors.
Kempkensteffen C; Hinz S; Krause H; Jager T; Köllermann J; Weikert S; Christoph F; Schostak M; Miller K; Schrader M
Tumour Biol; 2008; 29(2):76-82. PubMed ID: 18515985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
